With respect to the definition of HER2 heterogeneity, the same as surgical specimen, if all tumor cells overexpressed HER2 protein with IHC 3+ or 2+ on all biopsy specimens, the tumor was defined as the Homo-HER2-positive group. This evidence concerns the gene ERBB2 and neoplasm.